Evidence map›Paper›PMID 36901741›Full record

ArticleInternational journal of molecular sciences2023

circRNA from

Amaya Urdánoz-Casado, Javier Sánchez-Ruiz de Gordoa, Maitane Robles, Miren Roldan, Mónica Macías Conde, Blanca Acha, Idoia Blanco-Luquin, Maite Mendioroz

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Whole genome circRNA profiling ofDrug metabolism and personalized therapy · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. The Internal Ribosome Entry Site in Circular RNAs.Advances in experimental medicine and biology · 2025
    Review
  11. Circular RNAs as Biomarkers in the Diagnosis of Human Diseases.Advances in experimental medicine and biology · 2025
    Review
  12. Review
  13. Article
  14. The Role of Circular RNAs in Ischemic Stroke.Neurochemical research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Amaya Urdánoz-CasadoNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.ORCID 0000-0002-6312-8330
Javier Sánchez-Ruiz de GordoaNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.
Maitane RoblesNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.
Miren RoldanNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.ORCID 0000-0002-7102-569X
Mónica Macías CondeNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.
Blanca AchaNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.
Idoia Blanco-LuquinNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.ORCID 0000-0003-2917-586X
Maite MendiorozNeuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra-IdiSNA (Navarra Institute for Health Research), Universidad Pública de Navarra (UPNA), Pamplona, 31008 Navarra, Spain.
Universidad Publica de Navarra · ES

Funding

Departamento de Industria, Energía e Innovación de Gobierno de Navarra "Doctorados industriales 2018-2020"Departamento de Salud de Gobierno de Navarra "Contrato predoctoral en investigación en ciencias y tecnologías de la salud en el periodo 2019-2022"Fundación Bancaria "la Caixa" y Fundación Caja-Navarra "Programa de intensificación" (LCF/PR/PR15/51100006)Instituto de Salud Carlos III FI18/00150Instituto de Salud Carlos III FIS PI20/01701Instituto de Salud Carlos III INT19/00029Ministerio de Ciencia e innovación, Gobierno de España CM20/0024
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common cause of age-related dementia. Amyloid precursor protein (

Indexed as

Alzheimer DiseaseMicroRNAsAmyloid beta-Protein PrecursorBrainHumansRNA, CircularAmyloid beta-Protein PrecursorAPP protein, humanMicroRNAsRNA, CircularAlzheimer’s diseaseAmyloid betaAPPcircRNAentorhinal cortexmRNA

Identifiers

PMID36901741
PMCPMC10002054
OpenAlexW4321496987

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.